Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tivic Health Systems (TIVC) Depreciation & Amortization (CF) (2021 - 2025)

Historic Depreciation & Amortization (CF) for Tivic Health Systems (TIVC) over the last 5 years, with Q2 2025 value amounting to $1000.0.

  • Tivic Health Systems' Depreciation & Amortization (CF) changed 0.0% to $1000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $2000.0, marking a year-over-year decrease of 6000.0%. This contributed to the annual value of $3000.0 for FY2024, which is 6250.0% down from last year.
  • Latest data reveals that Tivic Health Systems reported Depreciation & Amortization (CF) of $1000.0 as of Q2 2025, which was down 0.0% from $1000.0 recorded in Q1 2025.
  • Tivic Health Systems' Depreciation & Amortization (CF)'s 5-year high stood at $3000.0 during Q3 2022, with a 5-year trough of $1000.0 in Q3 2023.
  • Its 5-year average for Depreciation & Amortization (CF) is $1823.5, with a median of $2000.0 in 2021.
  • In the last 5 years, Tivic Health Systems' Depreciation & Amortization (CF) skyrocketed by 5000.0% in 2022 and then plummeted by 6666.67% in 2023.
  • Over the past 5 years, Tivic Health Systems' Depreciation & Amortization (CF) (Quarter) stood at $2000.0 in 2021, then skyrocketed by 50.0% to $3000.0 in 2022, then crashed by 33.33% to $2000.0 in 2023, then tumbled by 50.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $1000.0 in Q2 2025, compared to $1000.0 in Q1 2025 and $1000.0 in Q3 2024.